植耀輝: 美股急跌拖累 恆指回試19,000點支持
耀才證券研究部總監植耀輝稱,港股昨日表現相當反覆,雖然大部分時間錄得升幅,但尾市隨著騰訊(00700.HK)及美團(03690.HK)倒跌,恆指亦未能維持升幅,最終恆指下跌35點,收報19,326點,成交則維持在950億元水平。
成份中表現最好為萬洲(00288.HK),升幅達到4%,但最受關注反而是下跌股份,當中藥明(02269.HK)便大跌近2成,事緣美國總統拜登簽署行政指令,將扶持本土生物科技行業。相關消息無疑不利藥明於當地業務之發展,惟短期內有關影響料不大,由於股價跌幅不少,故出現反彈並不出奇,只是業務前景似乎面對相當大挑戰,加上相關板塊時有不利消息,故還是不宜在現水平搏反彈。
至於整體大市表現,隔晚美國公布之CPI數據高於市場預期,導致隔晚美股急挫,納指跌幅更超過5%,今早亞太股市亦出現顯著下跌,預期港股亦會受到拖累,惟筆者相信即使港股下跌,預期19,000點附近亦會有一定支持,當然後市亦要視乎A股走向。
筆者並未持有相關股份~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.